Skip to main content

Table 1 Patient and tumour characteristics

From: Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance

Characteristics

No. (%)

All patients

104 (100)

Age (years; mean 56.2)

 

   ≤ 50

33 (32)

   51–60

29 (28)

   >60

42 (40)

Menopause

 

   Premenopausal

30 (29)

   Postmenopausal

74 (71)

Grade

 

   2

71 (68)

   3

33 (32)

pTb

 

   1

17 (16)

   2

86 (83)

   4

1 (1)

pNb

 

   0

29 (28)

   1

75 (72)

pMb

 

   0

104 (100)

Stageb

 

   I

3 (3)

   IIa

40 (38)

   IIb

60 (58)

   IIIb

1 (1)

Histology

 

   Ductal

103 (99)

   Scirrhous

1 (1)

Therapya

 

   Tamoxifen

70 (67)

   Radiotherapy

51 (49)

   Cyclophosphamide/Methotrexate/5-Fluorouracil

28 (27)

   Cyclophosphamide/Adriamycin/5-Fluorouracil

1 (1)

   Cyclophosphamide/Adriamycin

1 (1)

   Progesterone

1 (1)

   Letrozol

1 (1)

  1. aSome patients received more than one special treatment.
  2. bAccording to [15]